Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

6.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Master Transcription Regulators02:23

Master Transcription Regulators

8.1K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.1K
MicroRNAs01:22

MicroRNAs

4.4K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K
MicroRNAs01:22

MicroRNAs

25.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
25.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short-term quantitative CT trajectories of pulmonary Ground-Glass nodules during immune checkpoint inhibitor Therapy: A matched surveillance cohort study.

European journal of radiology·2026
Same author

Anchoring-Induced Interphase via Dual Mortise-Tenon Interactions for Synergistic Stabilization of Surface Co and O in High-Voltage LiCoO<sub>2</sub> Cathodes.

Angewandte Chemie (International ed. in English)·2026
Same author

Dual-substrate-based full-color fluorescent probe TPE-4PA@Tb/Eu-GMP-acac ICPs for alkaline phosphatase detection and its on-site application for algal bloom alert.

Talanta·2026
Same author

Heated nebulization of ambroxol hydrochloride: engineering submicron aerosols for pulmonary drug delivery.

International journal of pharmaceutics·2026
Same author

The prognostic and immunological role of NADPH oxidase in early and locally advanced lung adenocarcinoma.

Discover oncology·2026
Same author

Multimodal Distillation and Fusion for Enhanced Age-Related Macular Degeneration Classification.

IEEE journal of biomedical and health informatics·2026

Related Experiment Video

Updated: Apr 19, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K

A decrease in miR-150 regulates the malignancy of pancreatic cancer by targeting c-Myb and MUC4.

Ke Yang1, Miaoxia He, Zailong Cai

  • 1From the *Department of Pathology, Changhai Hospital, Second Military Medical University; and †Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai, China.

Pancreas
|December 19, 2014
PubMed
Summary

MicroRNA-150 (miR-150) acts as a tumor suppressor in pancreatic cancer. Lower miR-150 levels correlate with higher mortality, suggesting its role in regulating cancer progression.

More Related Videos

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

4.4K
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

967

Related Experiment Videos

Last Updated: Apr 19, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

9.1K
Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer
06:20

Syngeneic Mouse Orthotopic Allografts to Model Pancreatic Cancer

Published on: October 4, 2022

4.4K
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

967

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic cancer exhibits high mortality with limited treatment efficacy.
  • The specific role of the oncogene miR-150 in pancreatic cancer remains under-investigated.

Purpose of the Study:

  • To investigate the role of miR-150 in the tumorigenesis of pancreatic cancer.
  • To determine the impact of miR-150 on pancreatic cancer cell proliferation and malignancy.

Main Methods:

  • Analysis of miR-150, c-Myb, and MUC4 expression in 106 pancreatic ductal adenocarcinomas and adjacent benign tissues.
  • In vitro and in vivo functional studies using pancreatic cancer cell lines to assess miR-150's effects.
  • Correlation analysis of miR-150 expression with survival rates and oncogenic markers.

Main Results:

  • miR-150 expression was significantly reduced in pancreatic tumors compared to benign tissues.
  • Low miR-150 expression was associated with increased patient mortality.
  • miR-150 overexpression inhibited cell growth, migration, invasion, and induced apoptosis in pancreatic cancer cells.
  • miR-150 expression inversely correlated with c-Myb and MUC4 in various models.

Conclusions:

  • miR-150 functions as a crucial suppressor of pancreatic ductal carcinoma.
  • miR-150 regulates the aggressive progression of pancreatic cancer by modulating c-Myb and MUC4.